NCT05108077Unknown1 期
Treatment of Metastatic Tumors of the Urogenital Area (Bladder Cancer, Renal Cancel) With Cytokine-induced Killer Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年3月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- The relapse-free survival
研究概览
简要总结
Treatment of metastatic tumors of the urogenital area with cytokine-induced killer cells
详细描述
Treatment of metastatic tumors of the urogenital area using autologous cytokine-induced killer cells
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically confirmed diagnosis of pTa metastatic tumors of the urogenital area;
- •Patient who require repetitive transurethral resection;
- •Expression of muc-1/wt-1 by the tumor;
- •EGOC 0-3;
排除标准
- •any medical condition which can be associated with the high risk for the patient;
- •pregnancy/lactation;
- •chronic infections, including hepatitis B/C, tuberculosis, HIV
结局指标
主要结局
The relapse-free survival
时间窗: 3 year
The duration of relapse-free survival
Adverse effects associated with the therapy
时间窗: 1 year
Determination of adverse effects associated with the therapy
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi ArabiaMetastatic Urothelial CancerNCT06505746Astellas Pharma Singapore Pte. Ltd.287
招募中
1 期
Targeting Androgen Signaling in Urothelial Cell Carcinoma - NeoadjuvantUrothelial Carcinoma BladderAndrogen Receptor PositiveNCT05839119Brown University32
已完成
不适用
Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)Uterine CancerNCT06401265Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation8,000
已完成
不适用
Cellular Immunity and Renal Cell CancerNK Cell Mediated ImmunityNK Cell Cytokine ProductionKidney CancerNCT04377113Clinical Hospital Center Rijeka60
进行中（未招募）
2 期
Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical CystectomyBladder Cancer, MetastaticBladder CancerNCT04138628Jørgen Bjerggaard Jensen154